Robert L. van Nostrand, Director at Intra-Cellular Therapies, Inc. (ITCI), sold 30,000 shares at $56.80 ($1.7M) on 2022-08-11, disclosed to the SEC on 2022-08-12.
Open-market sale of $1.7M ITCI by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $56.80 | 1,500 | $85K | 5.0% |
| 2 | $57.15 | 28,500 | $1.6M | 95.0% |
| Total | $57.13 avg | 30,000 | $1.7M | 100% |
| Filing → |
| ITCI | SELL | 2024-02-28 | $2.9M | — | Filing → |
| ITCI | SELL | 2023-04-19 | $630K | — | Filing → |
| MBLX | BUY | 2012-12-04 | $21K | — | Filing → |